These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2824692)

  • 21. Sex, age, and training modulate spatial memory in the rhesus monkey (Macaca mulatta).
    Lacreuse A; Kim CB; Rosene DL; Killiany RJ; Moss MB; Moore TL; Chennareddi L; Herndon JG
    Behav Neurosci; 2005 Feb; 119(1):118-26. PubMed ID: 15727518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry.
    Morrow BA; George TP; Roth RH
    Brain Res; 2004 Nov; 1027(1-2):173-8. PubMed ID: 15494168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys.
    Arnsten AF; Goldman-Rakic PS
    Neurobiol Aging; 1990; 11(6):583-90. PubMed ID: 1980719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing.
    Turetsky BI; Fein G
    Psychophysiology; 2002 Mar; 39(2):147-57. PubMed ID: 12212663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys.
    Jackson WJ; Buccafusco JJ
    Pharmacol Biochem Behav; 1991 May; 39(1):79-84. PubMed ID: 1924516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys.
    Arnsten AF; Jentsch JD
    Pharmacol Biochem Behav; 1997 Sep; 58(1):55-9. PubMed ID: 9264070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonidine-induced hyperphagia in monkeys: evidence for alpha 2-noradrenergic receptor mediation.
    Schlemmer RF; Elder JK; Casper RC; Davis JM
    Psychopharmacology (Berl); 1981; 73(1):99-100. PubMed ID: 6262851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment.
    Murphy BL; Arnsten AF; Jentsch JD; Roth RH
    J Neurosci; 1996 Dec; 16(23):7768-75. PubMed ID: 8922432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey.
    Brozoski TJ; Brown RM; Rosvold HE; Goldman PS
    Science; 1979 Aug; 205(4409):929-32. PubMed ID: 112679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task.
    Buccafusco JJ; Webster SJ; Terry AV; Kille N; Blessing D
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):477-85. PubMed ID: 18784917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual contributions of noradrenaline to behavioural flexibility and motivation.
    Jahn CI; Gilardeau S; Varazzani C; Blain B; Sallet J; Walton ME; Bouret S
    Psychopharmacology (Berl); 2018 Sep; 235(9):2687-2702. PubMed ID: 29998349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine.
    Sandin M; Jasmin S; Levere TE
    Neurobiol Aging; 1990; 11(5):573-5. PubMed ID: 2234289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A method for the microdialysis of the cerebral cortex in research on the neurophysiological correlates of cognitive processes in monkeys].
    Dudkin KN; Kruchinin VK; Chueva IV; Samoĭlov MO; Lazarevich IV
    Fiziol Zh Im I M Sechenova; 1994 Oct; 80(10):128-32. PubMed ID: 7536535
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of efficacy of clonidine on memory in aged cebus monkeys.
    Bartus RT; Dean RL
    Neurobiol Aging; 1988; 9(4):409-11. PubMed ID: 3185860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noradrenergic dysfunction in Alzheimer's disease.
    Gannon M; Che P; Chen Y; Jiao K; Roberson ED; Wang Q
    Front Neurosci; 2015; 9():220. PubMed ID: 26136654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tracemetals, neuromelanin and neurodegeneration: An interesting area for research.
    Sathyanarayana Rao TS; Zecca L; Rao KJ
    Indian J Psychiatry; 2007 Jul; 49(3):154-6. PubMed ID: 20661375
    [No Abstract]   [Full Text] [Related]  

  • 37. A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?
    Fitzgerald PJ
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):171-82. PubMed ID: 20386882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.
    Bartus RT; Dean RL
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):15-36. PubMed ID: 19011839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.
    Zucca FA; Bellei C; Giannelli S; Terreni MR; Gallorini M; Rizzio E; Pezzoli G; Albertini A; Zecca L
    J Neural Transm (Vienna); 2006 Jun; 113(6):757-67. PubMed ID: 16755380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
    Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.